Internal Medicine, Clinical Cardiatric Electrophysiology · Springfield, IL
NPI
1740362094
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
9
Medicare group memberships
Hospitals
5
Hospital affiliations
619 E Mason St, Suite 4p57
Springfield, IL, 62701
Phone (217) 788-0706
Groups this clinician bills Medicare through
Medicare paid, 2024
$537K
6,631 services
Medicare patients, 2024
1,238
Average age 77
Drug cost, 2024
$1.0M
2,220 prescriptions
Company payments, 2025
$39K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ziad F Issa was code 93296 (external electrocardiographic monitoring), 1,298 times for 540 patients. In total Ziad F Issa billed 6,631 services in 73 codes, and Medicare paid $537K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 1,298 | 540 | $13.06 | $17K |
| 93294 External Electrocardiographic Monitoring | Office | 819 | 348 | $19.37 | $16K |
| 93010 Electrocardiogram | Office | 470 | 408 | $6.47 | $3,043 |
| 93295 External Electrocardiographic Monitoring | Office | 468 | 200 | $23.63 | $11K |
| 93005 Electrocardiogram | Office | 466 | 405 | $4.80 | $2,239 |
| 93280 External Electrocardiographic Monitoring | Office | 286 | 188 | $29.15 | $8,336 |
| 99152 Anesthesia | Facility | 249 | 223 | $10.01 | $2,493 |
| 93000 Electrocardiogram | Office | 244 | 224 | $8.22 | $2,005 |
| 93298 External Electrocardiographic Monitoring | Office | 219 | 40 | $65.27 | $14K |
| 93229 Electrocardiogram | Office | 197 | 179 | $602.39 | $119K |
| 93228 Electrocardiogram | Office | 196 | 178 | $19.17 | $3,758 |
| 99232 Hospital E&M - Subsequent | Facility | 164 | 79 | $60.79 | $9,970 |
| 93284 External Electrocardiographic Monitoring | Office | 153 | 96 | $47.28 | $7,233 |
| 99215 Office E&M - Established | Office | 106 | 95 | $132.99 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 93 | 83 | $12.94 | $1,204 |
By year: 2022 $580K for 6,102 services; 2023 $639K for 7,528 services; 2024 $537K for 6,631 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ziad F Issa prescribed most often to Medicare patients was Eliquis (Apixaban), with 701 prescriptions and refills. In total Ziad F Issa wrote 2,220 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 701 | 1,252 | 149 | $719K |
| Dofetilide Generic | 261 | 579 | 60 | $110K |
| Metoprolol Succinate Generic | 237 | 601 | 74 | $3,926 |
| Amiodarone Hcl Generic | 216 | 515 | 76 | $1,735 |
| Flecainide Acetate Generic | 213 | 498 | 57 | $8,350 |
| Xarelto Rivaroxaban | 148 | 252 | 26 | $142K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 73 | 199 | 26 | $2,306 |
| Sotalol Sotalol Hcl | 49 | 132 | 14 | $691 |
| Carvedilol Generic | 44 | 99 | 16 | $242 |
| Amlodipine Besylate Generic | 27 | 74 | Under 11 | $148 |
| Losartan Potassium Generic | 27 | 78 | Under 11 | $237 |
| Propafenone Hcl Generic | 23 | 49 | Under 11 | $724 |
| Propafenone Hcl Er Propafenone Hcl | 22 | 42 | Under 11 | $4,466 |
| Metoprolol Tartrate Generic | 18 | 52 | Under 11 | $270 |
| Clopidogrel Clopidogrel Bisulfate | 16 | 40 | Under 11 | $195 |
Brand drugs: 874 claims; generic drugs: 1,346 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ziad F Issa $39K ($39K in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $38K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.